ImmunoRel solutie perfuzabila 5% Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

immunorel solutie perfuzabila 5%

reliance life sciences pvt. ltd. - immunoglobulinum umane - solutie perfuzabila - 5%

ImmunoRel solutie perfuzabila 5% Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

immunorel solutie perfuzabila 5%

reliance life sciences pvt. ltd. - immunoglobulinum umane - solutie perfuzabila - 5%

ATGAM 50 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

atgam 50 mg/ml

pfizer service company bv - belgia - imunoglobulina anti-limfocite (la cal) - conc. pt. sol. perf. - 50mg/ml - imunosupresoare imunosupresoare selective

Hizentra Uniunea Europeană - română - EMA (European Medicines Agency)

hizentra

csl behring gmbh - imunoglobuline umane normale (scig) - sindroame de imunodeficiență - seruri imune și imunoglobuline, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.

Flebogamma DIF (previously Flebogammadif) Uniunea Europeană - română - EMA (European Medicines Agency)

flebogamma dif (previously flebogammadif)

instituto grifols s.a. - imunoglobulina umană normală - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - seruri imune și imunoglobuline, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.

HUMAGLOBIN România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

humaglobin

human bioplazma manufacturing and trading ltd. - imunoglobulina normala pt. adm. intravasculara - pulb.+solv. pt. sol. perf. - 5% - imunoglobuline imunoglobulina umana normala